Literature DB >> 31840764

The Association between Fast Increase in Bone Turnover During the Menopause Transition and Subsequent Fracture.

Albert Shieh1, Gail A Greendale1, Jane A Cauley2, Arun S Karlamangla1.   

Abstract

CONTEXT: Bone turnover increases rapidly during the menopause transition (MT) and plateaus above premenopausal levels in early postmenopause. It is uncertain whether higher bone turnover is associated with fracture in midlife women with near-normal bone mineral density (BMD).
OBJECTIVE: Examine whether faster increases in bone turnover during the MT (2 years before to 2 years after the final menstrual period [FMP]), and greater bone turnover during early postmenopause (≥2 years after the FMP) are risk factors for subsequent fracture, accounting for BMD. DESIGN AND
SETTING: The Study of Women's Health Across the Nation, a longitudinal cohort study of the MT. PARTICIPANTS: A total of 484 women (initially pre- or early perimenopausal, who transitioned to postmenopause) with bone turnover (urine collagen type I N-telopeptide), BMD, and fracture data. MAIN OUTCOME MEASURE: Incident fracture after the MT.
RESULTS: Adjusting for age, race/ethnicity, fracture before the MT, cigarette use, body mass index, and study site in Cox proportional hazards regression, each SD increment in the rate of increase in bone turnover during the MT was associated with 24% greater hazard of incident fracture in postmenopause (P = .008). Accounting for the same covariates, each SD increment in bone turnover during early postmenopause was associated with a 27% greater hazard of fracture (P = .01). Associations remained significant after controlling for MT rate of change and early postmenopausal level of BMD.
CONCLUSION: Faster increases in bone turnover during the MT and greater bone turnover in early postmenopause forecast future fractures. © Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  biochemical markers of bone turnover; general population studies; menopause; osteoporosis

Mesh:

Year:  2020        PMID: 31840764      PMCID: PMC7067542          DOI: 10.1210/clinem/dgz281

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   6.134


  31 in total

Review 1.  How can bone turnover modify bone strength independent of bone mass?

Authors:  C J Hernandez
Journal:  Bone       Date:  2008-02-20       Impact factor: 4.398

2.  Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity.

Authors:  MaryFran R Sowers; Huiyong Zheng; Gail A Greendale; Robert M Neer; Jane A Cauley; Jayne Ellis; Sarah Johnson; Joel S Finkelstein
Journal:  J Clin Endocrinol Metab       Date:  2013-05-10       Impact factor: 5.958

3.  Urinary N-telopeptide and Rate of Bone Loss Over the Menopause Transition and Early Postmenopause.

Authors:  Albert Shieh; Shinya Ishii; Gail A Greendale; Jane A Cauley; Joan C Lo; Arun S Karlamangla
Journal:  J Bone Miner Res       Date:  2016-10-21       Impact factor: 6.741

4.  Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.

Authors:  P Szulc; M C Chapuy; P J Meunier; P D Delmas
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

5.  Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study.

Authors:  P Vergnaud; P Garnero; P J Meunier; G Bréart; K Kamihagi; P D Delmas
Journal:  J Clin Endocrinol Metab       Date:  1997-03       Impact factor: 5.958

6.  Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women.

Authors:  R D Chapurlat; P Garnero; E Sornay-Rendu; M E Arlot; B Claustrat; P D Delmas
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

7.  Biochemical markers as predictors of rates of bone loss after menopause.

Authors:  A Rogers; R A Hannon; R Eastell
Journal:  J Bone Miner Res       Date:  2000-07       Impact factor: 6.741

8.  Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients.

Authors:  Robert Recker; Joan Lappe; K Michael Davies; Robert Heaney
Journal:  J Bone Miner Res       Date:  2004-07-21       Impact factor: 6.741

Review 9.  Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.

Authors:  S Vasikaran; R Eastell; O Bruyère; A J Foldes; P Garnero; A Griesmacher; M McClung; H A Morris; S Silverman; T Trenti; D A Wahl; C Cooper; J A Kanis
Journal:  Osteoporos Int       Date:  2010-12-24       Impact factor: 4.507

10.  Bone turnover markers after the menopause: T-score approach.

Authors:  Fatma Gossiel; Hibatallah Altaher; David M Reid; Christian Roux; Dieter Felsenberg; Claus-C Glüer; Richard Eastell
Journal:  Bone       Date:  2018-03-15       Impact factor: 4.398

View more
  4 in total

1.  Faster Lumbar Spine Bone Loss in Midlife Predicts Subsequent Fracture Independent of Starting Bone Mineral Density.

Authors:  Albert Shieh; Arun S Karlamangla; Mei-Hua Huang; Weijuan Han; Gail A Greendale
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

2.  Bone loss markers in the earliest Pacific Islanders.

Authors:  Justyna J Miszkiewicz; Frédérique Valentin; Christina Vrahnas; Natalie A Sims; Jitraporn Vongsvivut; Mark J Tobin; Geoffrey Clark
Journal:  Sci Rep       Date:  2021-02-17       Impact factor: 4.379

Review 3.  Critical Role of Estrogens on Bone Homeostasis in Both Male and Female: From Physiology to Medical Implications.

Authors:  Noirrit-Esclassan Emmanuelle; Valera Marie-Cécile; Trémollieres Florence; Arnal Jean-François; Lenfant Françoise; Fontaine Coralie; Vinel Alexia
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

4.  Sex Difference in the Association of Osteoporosis and Osteopenia Prevalence in Patients with Adrenal Adenoma and Different Degrees of Cortisol Excess.

Authors:  Shoichiro Izawa; Kazuhisa Matsumoto; Kazuhiko Matsuzawa; Takuyuki Katabami; Takanobu Yoshimoto; Michio Otsuki; Masakatsu Sone; Yoshiyu Takeda; Shintaro Okamura; Takamasa Ichijo; Mika Tsuiki; Tomoko Suzuki; Mitsuhide Naruse; Akiyo Tanabe
Journal:  Int J Endocrinol       Date:  2022-03-18       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.